Index RUT
P/E -
EPS (ttm) -0.29
Insider Own 7.44%
Shs Outstand 38.43M
Perf Week 21.78%
Market Cap 33.81M
Forward P/E -
EPS next Y -0.29
Insider Trans 6.00%
Shs Float 35.58M
Perf Month -13.77%
Enterprise Value 33.56M
PEG -
EPS next Q -0.09
Inst Own 44.33%
Short Float 9.29%
Perf Quarter -17.80%
Income -12.02M
P/S 0.81
EPS this Y -128.75%
Inst Trans -13.26%
Short Ratio 2.12
Perf Half Y -71.26%
Sales 41.64M
P/B 2.31
EPS next Y 20.77%
ROA -47.71%
Short Interest 3.31M
Perf YTD -86.34%
Book/sh 0.38
P/C 2.69
EPS next 5Y -4.96%
ROE -100.51%
52W High 7.17 -87.73%
Perf Year -82.72%
Cash/sh 0.33
P/FCF -
EPS past 3/5Y 55.74% 62.04%
ROIC -48.32%
52W Low 0.71 23.70%
Perf 3Y 62.87%
Dividend Est. -
EV/EBITDA -
Sales past 3/5Y 32.93% 53.36%
Gross Margin 66.56%
Volatility 10.41% 9.12%
Perf 5Y -84.01%
Dividend TTM -
EV/Sales 0.81
EPS Y/Y TTM -25.54%
Oper. Margin -28.51%
ATR (14) 0.08
Perf 10Y -
Dividend Ex-Date -
Quick Ratio 2.10
Sales Y/Y TTM 64.99%
Profit Margin -28.86%
RSI (14) 50.80
Recom 1.00
Dividend Gr. 3/5Y - -
Current Ratio 2.49
EPS Q/Q -240.78%
SMA20 6.00%
Beta 1.03
Target Price 5.00
Payout -
Debt/Eq 0.84
Sales Q/Q 9.59%
SMA50 -6.66%
Rel Volume 0.82
Prev Close 0.84
Employees 185
LT Debt/Eq 0.70
Earnings Nov 10 AMC
SMA200 -66.90%
Avg Volume 1.56M
Price 0.88
IPO Jun 12, 2017
Option/Short Yes / Yes
EPS/Sales Surpr. 16.67% 6.92%
Trades
Volume 569,649
Change 4.96%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-31-24 Initiated
Craig Hallum
Buy
$7
May-20-24 Initiated
Lake Street
Buy
$7
Dec-15-23 Initiated
H.C. Wainwright
Buy
$6.50
Nov-11-20 Upgrade
ROTH Capital
Neutral → Buy
$5 → $7
May-27-20 Initiated
Dougherty & Company
Buy
$8.50
Oct-02-17 Initiated
H.C. Wainwright
Buy
$12
Nov-11-25 12:02AM
Nov-10-25 05:35PM
Nov-06-25 07:20AM
Aug-12-25 03:00PM
Aug-11-25 07:00PM
04:05PM
Loading…
04:05PM
Aug-08-25 09:32AM
Aug-04-25 04:05PM
Jul-10-25 12:40AM
Jun-25-25 08:56AM
Jun-18-25 08:30AM
May-08-25 03:31AM
May-07-25 09:00PM
09:00PM
06:25PM
05:11PM
Loading…
05:11PM
May-01-25 08:30AM
Apr-30-25 04:05PM
08:05AM
Apr-10-25 08:30AM
Apr-09-25 06:03AM
Mar-31-25 04:05PM
Mar-11-25 01:12PM
(Thomson Reuters StreetEvents) +40.77%
03:03AM
Mar-10-25 05:15PM
04:05PM
Mar-07-25 07:06AM
Mar-03-25 04:05PM
Dec-05-24 07:30AM
Dec-04-24 04:05PM
02:22AM
Loading…
Nov-07-24 02:22AM
Nov-06-24 06:00PM
04:05PM
Nov-05-24 08:07AM
Oct-31-24 04:05PM
Oct-30-24 04:05PM
Oct-18-24 05:01PM
Oct-09-24 05:08PM
04:05PM
Sep-12-24 08:30AM
Sep-05-24 04:15PM
Aug-06-24 04:05PM
Jul-30-24 04:05PM
(Business Wire) -5.53%
+7.21%
Jul-27-24 07:40AM
Jul-26-24 06:05PM
Jul-08-24 08:30AM
Jun-11-24 10:50AM
Jun-05-24 05:58PM
Jun-01-24 02:42AM
May-17-24 07:01PM
May-10-24 04:03PM
01:01PM
May-09-24 01:16PM
May-08-24 04:05PM
May-06-24 01:19PM
08:30AM
May-01-24 05:21PM
(Business Wire) +7.95%
+11.05%
Mar-28-24 04:05PM
(Business Wire) -6.57%
-5.50%
Mar-18-24 11:00AM
Mar-08-24 10:15AM
Mar-07-24 06:00PM
04:05PM
Mar-01-24 08:00AM
Feb-29-24 04:05PM
Jan-19-24 04:05PM
Jan-17-24 08:05AM
08:00AM
Dec-20-23 08:50AM
Dec-12-23 07:00AM
Dec-01-23 10:00AM
Nov-20-23 04:16PM
Nov-08-23 11:47AM
Nov-07-23 04:05PM
Nov-06-23 08:30AM
Nov-02-23 10:08AM
Oct-31-23 04:05PM
Aug-29-23 04:05PM
Aug-28-23 12:38PM
Aug-25-23 07:00AM
Aug-24-23 07:33PM
04:15PM
04:05PM
Aug-21-23 04:05PM
(Business Wire) +10.80%
-6.91%
Aug-09-23 05:30PM
04:05PM
Aug-02-23 04:05PM
Jul-05-23 10:50AM
Jul-03-23 08:30AM
Jun-14-23 04:05PM
May-22-23 09:55AM
May-10-23 06:05PM
May-09-23 07:05PM
May-05-23 07:45AM
May-03-23 04:05PM
Apr-10-23 08:30AM
Mar-16-23 05:30AM
(The Wall Street Journal)
Mar-15-23 08:30AM
Mar-14-23 11:11AM
Mar-13-23 09:45AM
08:30AM
Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KIRK THOMAS F Director Nov 20 '25 Buy 0.72 4,902 3,529 479,322 Nov 24 04:04 PM KIRK THOMAS F Director Nov 21 '25 Buy 0.72 2,535 1,825 481,857 Nov 24 04:04 PM Crowley Thomas Aloysius Jr. Director Nov 18 '25 Buy 0.73 4,000 2,938 75,748 Nov 21 07:22 PM Crowley Thomas Aloysius Jr. Director Nov 19 '25 Buy 0.77 385 295 479 Nov 21 07:22 PM KIRK THOMAS F Director Aug 25 '25 Buy 1.15 50,000 57,500 474,420 Aug 26 08:10 AM KIRK THOMAS F Director Aug 18 '25 Buy 1.10 50,000 55,000 424,420 Aug 19 07:23 AM GUDONIS PAUL R Chief Executive Officer Aug 15 '25 Buy 0.95 50,000 47,295 1,259,013 Aug 18 07:51 AM David Henry Officer Jun 30 '25 Proposed Sale 2.19 23,587 51,656 Jun 30 08:12 PM Harry Kovelman Officer Jun 28 '25 Proposed Sale 2.19 13,054 28,588 Jun 30 08:04 PM Harry Kovelman Officer Jun 06 '25 Proposed Sale 2.97 5,743 17,057 Jun 06 07:08 PM David Henry Officer Jun 06 '25 Proposed Sale 2.97 8,373 24,868 Jun 06 06:50 PM KIRK THOMAS F Director May 15 '25 Buy 3.25 36,824 119,678 344,700 May 15 04:53 PM KIRK THOMAS F Director May 14 '25 Buy 3.25 1,943 6,315 307,876 May 15 04:53 PM GUDONIS PAUL R Chief Executive Officer May 15 '25 Buy 3.22 30,000 96,612 1,051,671 May 15 04:36 PM KIRK THOMAS F Director May 12 '25 Buy 3.35 50,000 167,500 305,933 May 14 08:27 AM KIRK THOMAS F Director Mar 13 '25 Buy 5.00 7,400 37,000 255,933 Mar 14 09:00 PM Mitchell Micah Chief Commercial Officer Mar 14 '25 Sale 5.16 48,000 247,565 140,572 Mar 14 05:36 PM MICAH MITCHELL Officer Mar 14 '25 Proposed Sale 5.16 48,000 247,565 Mar 14 05:24 PM Kovelman Harry Chief Medical Officer Mar 12 '25 Sale 5.50 30,000 165,018 97,973 Mar 13 04:41 PM Micah Mitchell Officer Mar 13 '25 Proposed Sale 5.22 1,283 6,697 Mar 13 04:31 PM David Henry Officer Mar 13 '25 Proposed Sale 5.22 2,019 10,539 Mar 13 04:30 PM Harry Kovelman Officer Mar 13 '25 Proposed Sale 5.22 1,496 7,809 Mar 13 04:28 PM HARRY KOVELMAN Officer Mar 12 '25 Proposed Sale 5.50 30,000 165,015 Mar 12 04:59 PM GUDONIS PAUL R Chief Executive Officer Feb 13 '25 Option Exercise 0.05 694 33 1,014,963 Feb 18 04:33 PM